Pipline

Pipeline

Our pipeline focuses on addressing patients' unmet medical needs through the development of proprietary liposomal products and recombinant protein products.

»Learn more about ARIKACE™

»Get more information about IPLEX™

»See our Oncology Programs

Press Releases

Jan. 20, 2012
Insmed Incorporated Provides Corporate Update Read More
Nov. 14, 2011
Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference Read More